On the 17th, Xinhua Medical announced that the company had previously filed nine natural person contract disputes involving Hu Yong, Yang Zhongwu, Qiu Jiashan and Su Xiaodong. Recently, the company received a notice of acceptance of the case issued by the Zibo High-tech Zone Court and decided to file a case review. It is reported that according to the "Profit Compensation Agreement" signed by Xinhua Medical and Qu Yong and other people, Chengdu Yingde Biomedical Equipment Technology Co., Ltd. 2016 annual results did not meet expectations, and Qu Yong and other people need to compensate according to the company. However, during the agreed time limit (before June 1, 2017), Qu Yong and others will perform their compensation obligations. On June 2, 2017, the company filed a lawsuit in court. The reporter noted that Xinhua Medical announced the asset acquisition plan on April 18, 2014. It plans to acquire 85% of Chengdu Yingde and raise matching funds through the issuance of shares and payment of cash, so as to enter the blood and vaccine field equipment manufacturing and engineering. Service area. At that time, Qu Yong and others promised that the net profit of Chengdu Yingde from 2014 to 2017 was not less than 38 million yuan, 42.8 million yuan, 45.8 million yuan and 46.8 million yuan respectively. However, in 2014-2016, Chengdu Yingde failed to meet the standards for three consecutive years. During the period, the net profit after deduction was 31.633 million yuan, 32.5224 million yuan, and -50.577 million yuan. Shandong Xinhua Medical Equipment Co., Ltd. Puyang Linshi Medical Supplies Co., Ltd. , https://www.linshimedicals.com
Chengdu Yingde Biocommittee has been unable to compensate Xinhua Medical